Literature DB >> 10519401

Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes.

M A Cabrita1, T C Hobman, D L Hogue, K M King, C E Cass.   

Abstract

Mouse transporter protein (MTP), a small, highly conserved mammalian intracellular membrane protein with four putative transmembrane domains, has been implicated in the transport of nucleosides and/or related molecules across intracellular membranes. The production of recombinant MTP in Saccharomyces cerevisiae alters sensitivity of yeast cells to a heterogeneous group of compounds (e.g., antimetabolites, antibiotics, anthracyclines, ionophores, and steroid hormones) by changing the subcellular compartmentalization of these drugs, suggesting that MTP functions similarly in higher organisms. The present study was undertaken to define the intracellular location of MTP in mammalian cells. Native MTP was not detected by indirect immunofluorescence in cell types that expressed MTP mRNA; therefore, a hemagglutinin (HA) epitope-tagged version of MTP was produced in cultured BHK21 cells by transient transfection, and its distribution within cells was determined by confocal microscopy using antibodies directed against the HA epitope and various organellar proteins. Antibodies directed against HA-MTP colocalized with antibodies against late endosomal and lysosomal proteins but not with antibodies against either Golgi or early endosomal proteins. Analysis of subcellular fractions from rat liver by immunoblotting with antibodies directed against MTP demonstrated the presence of a MTP-like protein in Golgi- and lysosome-enriched membranes but not in mitochondria. These results indicate that MTP resides in late endosomes and lysosomes, a finding that is consistent with the proposed role for MTP in the movement of a variety of small molecules across endosomal and lysosomal membranes. MTP shares a number of characteristics with other lysosome-associated proteins. We, therefore, propose that it be redesignated murine lysosome-associated protein transmembrane 4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519401

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes.

Authors:  Douglas L Hogue; Colin Nash; Victor Ling; Tom C Hobman
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 3.  Lysosomal membrane proteomics and biogenesis of lysosomes.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

4.  Identification of human gene products containing Pro-Pro-x-Tyr (PY) motifs that enhance glutathione and endocytotic marker uptake in yeast.

Authors:  Shujie Shi; Sylvia Notenboom; Mark E Dumont; Nazzareno Ballatori
Journal:  Cell Physiol Biochem       Date:  2010-01-12

5.  LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

6.  LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment.

Authors:  A Grabner; S Brast; S Sucic; S Bierer; B Hirsch; H Pavenstädt; H H Sitte; E Schlatter; G Ciarimboli
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

7.  LAPTM4B facilitates late endosomal ceramide export to control cell death pathways.

Authors:  Tomas Blom; Shiqian Li; Andrea Dichlberger; Nils Bäck; Young Ah Kim; Ursula Loizides-Mangold; Howard Riezman; Robert Bittman; Elina Ikonen
Journal:  Nat Chem Biol       Date:  2015-08-17       Impact factor: 15.040

8.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

9.  Functional proteomics mapping of a human signaling pathway.

Authors:  Frédéric Colland; Xavier Jacq; Virginie Trouplin; Christelle Mougin; Caroline Groizeleau; Alexandre Hamburger; Alain Meil; Jérôme Wojcik; Pierre Legrain; Jean-Michel Gauthier
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

10.  Subcellular localization and activity of multidrug resistance proteins.

Authors:  Asha Rajagopal; Sanford M Simon
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.